The role of radiolabeling in BNCT tracers for enhanced dosimetry and treatment planning.
BNCT
PET
SPECT
radiolabeling
theranostics, targeted therapy
Journal
Theranostics
ISSN: 1838-7640
Titre abrégé: Theranostics
Pays: Australia
ID NLM: 101552395
Informations de publication
Date de publication:
2023
2023
Historique:
received:
09
08
2023
accepted:
15
09
2023
medline:
2
11
2023
pubmed:
1
11
2023
entrez:
1
11
2023
Statut:
epublish
Résumé
Positron emission tomography (PET) and single photon emission computed tomography (SPECT) are potent technologies for non-invasive imaging of pharmacological and biochemical processes in both preclinical and advanced clinical research settings. In the field of radiation therapy, boron neutron capture therapy (BNCT) stands out because it harnesses biological mechanisms to precisely target tumor cells while preserving the neighboring healthy tissues. To achieve the most favorable therapeutic outcomes, the delivery of boron-enriched tracers to tumors must be selective and efficient, with a substantial concentration of boron atoms meticulously arranged in and around the tumor cells. Although several BNCT tracers have been developed to facilitate the targeted and efficient delivery of boron to tumors, only a few have been labeled with PET or SPECT radionuclides. Such radiolabeling enables comprehensive
Identifiants
pubmed: 37908724
doi: 10.7150/thno.88998
pii: thnov13p5247
pmc: PMC10614688
doi:
Substances chimiques
Boron
N9E3X5056Q
Boron Compounds
0
Types de publication
Journal Article
Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
5247-5265Informations de copyright
© The author(s).
Déclaration de conflit d'intérêts
Competing Interests: The authors have declared that no competing interest exists.
Références
Colloids Surf B Biointerfaces. 2017 Nov 1;159:360-365
pubmed: 28806667
Nat Rev Drug Discov. 2008 Jul;7(7):591-607
pubmed: 18591980
Cancers (Basel). 2022 Jun 18;14(12):
pubmed: 35740674
Int J Radiat Biol. 2013 Aug;89(8):611-7
pubmed: 23484623
Eur J Nucl Med Mol Imaging. 2021 Sep;48(10):3113-3121
pubmed: 33590273
J Control Release. 2017 May 28;254:1-9
pubmed: 28336377
J Nucl Med. 2007 Oct;48(10):1741-8
pubmed: 17873136
Chem Commun (Camb). 2021 Sep 6;57(71):8953-8956
pubmed: 34486586
Nucl Med Commun. 2020 Jun;41(6):589-596
pubmed: 32282637
Sci Rep. 2016 Apr 18;6:24388
pubmed: 27087555
Nucl Med Biol. 2013 Jul;40(5):625-9
pubmed: 23557719
Biomaterials. 2015 Jul;56:10-7
pubmed: 25934274
J Nucl Cardiol. 2012 Feb;19 Suppl 1:S19-29
pubmed: 22160631
Front Phys. 2015 Apr;3:
pubmed: 28553633
Nat Commun. 2023 Apr 5;14(1):1884
pubmed: 37019890
J Pharmacol Sci. 2019 Mar;139(3):215-222
pubmed: 30833090
J Med Chem. 2022 Dec 22;65(24):16741-16753
pubmed: 36512639
Chem Commun (Camb). 2021 Jan 28;57(7):827-839
pubmed: 33399147
J Nucl Med. 2017 May;58(5):687-688
pubmed: 28408526
Yakugaku Zasshi. 2022;142(2):155-164
pubmed: 35110452
J Nucl Med. 1997 Nov;38(11):1762-7
pubmed: 9374349
Theranostics. 2016 Apr 12;6(6):887-95
pubmed: 27162558
Mol Pharm. 2019 Sep 3;16(9):3831-3841
pubmed: 31381351
J Neurosurg. 2005 Dec;103(6):1000-9
pubmed: 16381186
Cancer Res. 2002 Jun 1;62(11):3159-66
pubmed: 12036929
Molecules. 2019 Jul 23;24(14):
pubmed: 31340553
Radiat Oncol. 2011 Sep 05;6:106
pubmed: 21888676
J Nucl Med. 1998 Feb;39(2):325-33
pubmed: 9476945
Drug Discov Today Technol. 2006 Summer;3(2):187-94
pubmed: 24980407
Biology (Basel). 2020 Oct 07;9(10):
pubmed: 33036386
Biomacromolecules. 2015 Dec 14;16(12):3980-8
pubmed: 26564472
Nanomedicine. 2014 Apr;10(3):589-97
pubmed: 24161383
J Pers Med. 2021 Aug 23;11(8):
pubmed: 34442469
Clin Cancer Res. 2007 Feb 15;13(4):1260-8
pubmed: 17317838
ACS Appl Mater Interfaces. 2020 Dec 16;12(50):55564-55573
pubmed: 33327054
Eur J Pharm Sci. 2017 Sep 30;107:217-229
pubmed: 28728977
Bioconjug Chem. 2019 Nov 20;30(11):2870-2878
pubmed: 31593447
Clin Nucl Med. 2020 Nov;45(11):863-864
pubmed: 32969900
J Nucl Med. 2020 May;61(5):764-771
pubmed: 31628214
Pharm Res. 1996 Mar;13(3):344-51
pubmed: 8692724
Biomolecules. 2021 Nov 09;11(11):
pubmed: 34827657
J Nucl Med. 2007 Apr;48(4):661-73
pubmed: 17401106
J Am Chem Soc. 2005 Jul 13;127(27):9875-80
pubmed: 15998093
Eur J Nucl Med Mol Imaging. 2019 Jun;46(6):1222-1225
pubmed: 30859431
Cells. 2023 May 16;12(10):
pubmed: 37408232
Crit Rev Oncol Hematol. 2008 Oct;68(1):66-90
pubmed: 18439836
Colloids Surf B Biointerfaces. 2019 Nov 1;183:110387
pubmed: 31394419
Cancer. 2020 Aug 1;126(15):3560-3568
pubmed: 32426866
Chem Commun (Camb). 2013 Dec 21;49(98):11491-3
pubmed: 24175318
Radiat Res. 2012 Dec;178(6):609-21
pubmed: 23148506
Radiat Oncol. 2021 Nov 7;16(1):216
pubmed: 34743756
Nat Protoc. 2021 Jul;16(7):3348-3381
pubmed: 34127865
Jpn J Radiol. 2020 Apr;38(4):343-357
pubmed: 32043236
J Control Release. 2010 Nov 20;148(1):122-127
pubmed: 20547192
Clin Cancer Res. 2005 Jun 1;11(11):3987-4002
pubmed: 15930333
Eur Urol. 2018 Aug;74(2):179-190
pubmed: 29678358
Future Microbiol. 2020 Mar;15:319-332
pubmed: 32101035
Nanoscale Res Lett. 2008 Nov 25;4(2):113-121
pubmed: 20596476
Int J Rad Appl Instrum A. 1991;42(4):325-8
pubmed: 1850716
ACS Appl Mater Interfaces. 2018 Dec 19;10(50):43387-43395
pubmed: 30451482
J Nucl Med. 2003 Aug;44(8):1271-81
pubmed: 12902418
ACS Appl Mater Interfaces. 2021 Nov 24;13(46):54739-54752
pubmed: 34752058
Proc Natl Acad Sci U S A. 2008 Nov 11;105(45):17493-7
pubmed: 18981415
Rep Pract Oncol Radiother. 2018 Sep-Oct;23(5):462-473
pubmed: 30263016
Nat Rev Clin Oncol. 2012 Dec;9(12):712-20
pubmed: 23149896
Clin Cancer Res. 1998 Aug;4(8):1833-41
pubmed: 9717809
Molecules. 2019 Oct 07;24(19):
pubmed: 31591329
J Am Chem Soc. 2009 Jun 24;131(24):8376-7
pubmed: 19489551
Front Endocrinol (Lausanne). 2021 Jun 25;12:714348
pubmed: 34248856
Nucl Med Biol. 2020 Nov - Dec;90-91:55-68
pubmed: 33039974
Int J Radiat Oncol Biol Phys. 2011 Jun 1;80(2):369-76
pubmed: 21236605
J Med Chem. 2007 Feb 22;50(4):820-7
pubmed: 17253677
Curr Med Chem. 2013;20(3):378-88
pubmed: 23157630
Front Oncol. 2021 Feb 26;11:601820
pubmed: 33718149
J Neurosurg. 1995 Jul;83(1):86-92
pubmed: 7782856
J Nucl Med. 2015 Aug;56(8):1285-91
pubmed: 26135111
Ann N Y Acad Sci. 2011 Jun;1228:1-18
pubmed: 21718318
Chemistry. 2015 Mar 2;21(10):3924-8
pubmed: 25639468
Nat Commun. 2022 Apr 19;13(1):2143
pubmed: 35440126
Mol Pharm. 2022 Apr 4;19(4):1135-1145
pubmed: 35298163
Appl Radiat Isot. 2014 Jun;88:38-42
pubmed: 24393770
Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):247-52
pubmed: 16111595
J Control Release. 2004 Aug 11;98(2):195-207
pubmed: 15262412
Biomater Sci. 2020 May 19;8(10):2778-2785
pubmed: 32342085
J Neurooncol. 2011 Jun;103(2):175-85
pubmed: 20848301
Semin Nucl Med. 2022 May;52(3):276-285
pubmed: 35210065
J Nucl Med. 2020 Sep;61(9):1388-1396
pubmed: 31924718
J Mater Chem B. 2021 Jan 21;9(2):410-420
pubmed: 33367431
Clin Cancer Res. 2006 Jun 15;12(12):3792-802
pubmed: 16778107
ACS Omega. 2022 Dec 12;7(51):48340-48348
pubmed: 36591151
Front Chem. 2021 Mar 15;9:619052
pubmed: 33791278
Appl Radiat Isot. 2009 Jul;67(7-8 Suppl):S105-8
pubmed: 19375330
Bioconjug Chem. 2023 Mar 15;34(3):457-476
pubmed: 36811499
Molecules. 2019 Oct 02;24(19):
pubmed: 31581645
Mol Pharm. 2022 Feb 7;19(2):363-377
pubmed: 35040321
Proc Natl Acad Sci U S A. 2013 Apr 16;110(16):6512-7
pubmed: 23536304
Adv Mater. 2017 Aug;29(31):
pubmed: 28620939
Appl Radiat Isot. 2004 Nov;61(5):1089-93
pubmed: 15308197
Appl Radiat Isot. 2013 Apr;74:91-101
pubmed: 23395785